Reading the dates as a sequence: a clerical issue (a withdrawn nomination), a three-week regulatory gap (April 22 to May 5), a clarification, an updated reference document (May 14), and a future PCAC review that will run alongside the broader peptide policy fight already on the agency's calendar
Stem Cell and Hair Follicle Research exploration of GHK-Cus role in dermal and follicular signaling environments
O.AteahinA.SakinF.AslanA.eribaS.YipelM

Timeline: what to expect Semaglutide timeline Weeks 1-4 (0.25mg): Mild appetite reduction 2-4 pounds lost Minimal side effects at this low dose Still figuring out the medication Weeks 5-8 (0.5mg): Noticeable appetite suppression 4-6 pounds additional loss (6-10 total) Some nausea possible Starting to feel the effects Weeks 9-12 (1mg): Significant appetite reduction Consistent 1-2 pounds weekly 12-18 pounds total lost Side effects peak then improve Weeks 13-24 (1.7-2.4mg): Maximum appetite suppression Steady 1-2 pounds weekly continues 25-35 pounds total lost Side effects manageable for most Weeks 25-52: Weight loss slows as you approach new set point Maintenance phase begins 30-40 pounds total lost for most Continue medication to maintain Tirzepatide timeline Weeks 1-4 (2.5mg): Noticeable appetite reduction immediately 4-6 pounds lost More intense initial side effects possible Faster start than semaglutide Weeks 5-8 (5mg): Strong appetite suppression 6-8 pounds additional loss (10-14 total) GI side effects peak Rapid initial progress Weeks 9-16 (7.5-10mg): Maximum appetite suppression 2-3 pounds weekly 20-30 pounds total lost Finding your optimal dose Weeks 17-32 (10-15mg): Continued steady loss 35-50 pounds total for most Side effects stabilized Remarkable transformation visible Weeks 33-52: Approaching final weight Maintenance begins 40-55 pounds total lost Weight stabilization phase Tirzepatide works faster and produces more total weight loss

Other GLP-1 medications include Ozempic (semaglutide), Wegovy (semaglutide), and Saxenda
On a twice-weekly schedule targeting 8mg total, each injection is 4mg, which equals 0.8mL or 80 units on a standard insulin syringe